Received: 2 February 2021
Accepted: 20 July 2021
First Online: 6 September 2021
: The study is approved by the Ethical Review Board of the University of Nottingham (REF 3007 191023). An Animal Test Certificate (ATC-S-130) has been obtained from the Veterinary Medicines Directorate covering the use of formulations of amoxicillin-clavulanate with a marketing authorisation in the United Kingdom for a variable treatment duration. Informed consent will be obtained from all participating owners of dogs involved in this study.
: Not applicable.
: The authors declare that they have no competing interests.